The diagnostic accuracy of HE4 in lung cancer: A meta-analysis

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Cheng, Daye ^a   Sun, Ying ^a   He, Hu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN EPIDIDYMIS PROTEIN 4; PROTEIN; TUMOR MARKER; WFDC2 PROTEIN, HUMAN;

CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENERAL PATHOLOGICAL PARAMETERS; GENETIC HETEROGENEITY; HUMAN; LUNG CANCER; META ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; BLOOD; CASE CONTROL STUDY; LUNG TUMOR; METABOLISM;

BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; HUMANS; LUNG NEOPLASMS; PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 84926442752     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/352670     Document Type: Review

References (37)

1. J. She, P. Yang, Q. Hong, and C. Bai, "Lung cancer in China: challenges and interventions", Chest, Vol. 143, no. 4, pp. 1117-1126, 2013.
2. Q. Lan, R. S. Chapman, D. M. Schreinemachers, L. Tian, and X. He, "Household stove improvement and risk of lung cancer in Xuanwei, China", Journal of the National Cancer Institute, Vol. 94, no. 11, pp. 826-835, 2002.
3. A. Jemal, R. Siegel, J. Xu, and E. Ward, "Cancer statistics, 2010", CA Cancer Journal for Clinicians, Vol. 60, no. 5, pp. 277-300, 2010.
4. A. Jemal, R. Siegel, E. Ward et al., "Cancer statistics, 2008", CA-Cancer Journal for Clinicians, Vol. 58, no. 2, pp. 71-96, 2008.
5. M. Grunnet and J. B. Sorensen, "Carcinoembryonic antigen (CEA) as tumor marker in lung cancer", Lung Cancer, Vol. 76, no. 2, pp. 138-143, 2012.
6. A. Tufman and R. M. Huber, "Biological markers in lung cancer: a clinician's perspective", Cancer Biomarkers, Vol. 6, no. 3-4, pp. 123-135, 2009.
7. J. Kulpa, E. Wójcik, A. Radkowski, L. Kolodziejski, and Z. Stasik, "CYFRA 21-1, TPA-M, TPS, SCC-Ag and CEA in patients with squamous cell lung cancer and in chemical industry workers as a reference group", Anticancer Research, Vol. 20, no. 6, pp. 5035-5040, 2000.
8. P.-J. Lamy, J. Grenier, A. Kramar, and J.-L. Pujol, "Progastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer", Lung Cancer, Vol. 29, no. 3, pp. 197-203, 2000.
9. B. Nisman, H. Biran, N. Ramu, N. Heching, V. Barak, and T. Peretz, "The diagnostic and prognostic value of ProGRP in lung cancer", Anticancer Research, Vol. 29, no. 11, pp. 4827-4832, 2009.
10. E. Wójcik, J. K. Kulpa, B. Sas-Korczyńska, S. Korzeniowski, and J. Jakubowicz, "ProGRP and NSE in therapy monitoring in patients with small cell lung cancer", Anticancer Research, Vol. 28, no. 5, pp. 3027-3033, 2008.
11. A. Clauss, H. Lilja, and Å. Lundwall, "A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein", Biochemical Journal, Vol. 368, part 1, pp. 233-242, 2002.
12. C. Kirchhoff, "Molecular characterization of epididymal proteins", Reviews of Reproduction, Vol. 3, no. 2, pp. 86-95, 1998.
13. J. M. Escudero, J. M. Auge, X. Filella, A. Torne, J. Pahisa, and R. Molina, "Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases", Clinical Chemistry, Vol. 57, no. 11, pp. 1534-1544, 2011.
14. S.-I. Yamashita, K. Tokuishi, T. Hashimoto et al., "Prognostic significance of HE4 expression in pulmonary adenocarcinoma", Tumor Biology, Vol. 32, no. 2, pp. 265-271, 2011.
15. K. Iwahori, H. Suzuki, Y. Kishi et al., "Serum HE4 as a diagnostic and prognostic marker for lung cancer", Tumo ur Bi olo g y, Vol. 33, no. 4, pp. 1141-1149, 2012.
16. W. Liu, J. Yang, P. D. Chi et al., "Evaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosis", International Journal of Tuberculosis and Lung Disease, Vol. 17, no. 10, pp. 1346-1353, 2013.
17. E. Y. Ucar, A. L. Ozkaya, O. Araz et al., "Serum and bronchial aspiration fluid HE-4 levels in lung cancer", Tumor Biology, Vol. 35, no. 9, pp. 8795-8799, 2014.
18. X. Wang, Y. Fan, J. Wang, H. Wang, and W. Liu, "Evaluating the expression and diagnostic value of human epididymis protein 4 (HE4) in small cell lung cancer", Tumor Biology, Vol. 35, no. 7, pp. 6847-6853, 2014.
19. F. Yu, Q. Wang, D. Zhong et al., "The significance of serum HE4 levels in the diagnosis of lung cancer", Tianjin Medical Journal, Vol. 42, no. 2, pp. 116-118, 2014.
20. Y. Xiao, H. Hu, R. Wang et al., "Investigation on serum HE4 levels in the diagnosis of lung cancer", Laboratory Medicine, Vol. 29, no. 9, pp. 893-896, 2014.
21. P. Whiting, A. W. S. Rutjes, J. B. Reitsma, P. M. M. Bossuyt, and J. Kleijnen, "The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews", BMC Medical Research Methodology, Vol. 3, article 1, pp. 1-13, 2003.
22. L. E. Moses, D. Shapiro, and B. Littenberg, "Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations", Statistics in Medicine, Vol. 12, no. 14, pp. 1293-1316, 1993.
23. M. Egger, G. D. Smith, M. Schneider, and C. Minder, "Bias in meta-analysis detected by a simple, graphical test", British Medical Journal, Vol. 315, no. 7109, pp. 629-634, 1997.
24. D. Yin, Y. Jiang, N. Wang et al., "The diagnostic value of serum hybrid capture 2 (CH2) HPV DNA in cervical cancer: a systematic review and meta-analysis", Tumor Biology, Vol. 35, no. 9, pp. 9247-9253, 2014.
25. A. Clauss, H. Lilja, and Å. Lundwall, "The evolution of a genetic locus encoding small serine proteinase inhibitors", Biochemical and Biophysical Research Communications, Vol. 333, no. 2, pp. 383-389, 2005.
26. S.-W. Jiang, H. Chen, S. Dowdy et al., "HE4 transcription-and splice variants-specific expression in endometrial cancer and correlation with patient survival", International Journal of Molecular Sciences, Vol. 14, no. 11, pp. 22655-22677, 2013.
27. M. Kamei, S.-I. Yamashita, K. Tokuishi et al., "HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer", Anticancer Research, Vol. 30, no. 11, pp. 4779-4783, 2010.
28. R. L. O'Neal, K. T. Nam, B. J. Lafleur et al., "Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarci-nomas", Human Pathology, Vol. 44, no. 5, pp. 734-742, 2013.
29. Z. Xi, M. LinLin, and T. Ye, "Human epididymis protein 4 is a biomarker for transitional cell carcinoma inthe urinary system", Journal of Clinical Laboratory Analysis, Vol. 23, no. 6, pp. 357-361, 2009.
30. R. Drapkin, H. H. von Horsten, Y. Lin et al., "Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas", Cancer Research, Vol. 65, no. 6, pp. 2162-2169, 2005.
31. A. C. Macedo, M. I. da Rosa, S. Lumertz, and L. R. Medeiros, "Accuracy of serum human epididymis protein 4 in ovarian cancer diagnosis: a systematic review and meta-analysis", International Journal of Gynecological Cancer, Vol. 24, no. 7, pp. 1222-1231, 2014.
32. E. Piovano, L. Attamante, C. Macchi et al., "The role of HE4 in ovarian cancer follow-up: a review", International Journal of Gynecological Cancer, Vol. 24, no. 8, pp. 1359-1365, 2014.
33. X.-Y. Chu, X.-B. Hou, W.-A. Song, Z.-Q. Xue, B. Wang, and L.B. Zhang, "Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: a single center analysis", Cancer Biology & Therapy, Vol. 11, no. 12, pp. 995-1000, 2011.
34. M. R. De Sousa and A. L. P. Ribeiro, "Systematic review and meta-analysis of diagnostic and prognostic studies: a tutorial", Arquivos Brasileiros de Cardiologia, Vol. 92, no. 3, pp. 235-245, 2009.
35. Z. Huang and F. Liu, "Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis", Tumor Biology, Vol. 35, no. 8, pp. 7459-7465, 2014.
36. S. D. Walter, "Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data", Statistics in Medicine, Vol. 21, no. 9, pp. 1237-1256, 2002.
37. M. D. Coory, "Comment on: heterogeneity in meta-analysis should be expected and appropriately quantified", International Journal of Epidemiology, Vol. 39, no. 3, Article ID dyp157, p. 932, 2009.